1. Qi, Zihao, Bai, Xiaojie, Wu, Linjie, Guo, Zhongqiang, Yu, Ying. 2024. CAPN2 promotes apalutamide resistance in metastatic hormone-sensitive prostate cancer by activating protective autophagy. In Journal of translational medicine, 22, 538. doi:10.1186/s12967-024-05335-z. https://pubmed.ncbi.nlm.nih.gov/38844946/
2. Yi, Tingzhuang, Wang, Chunming, Ye, Xia, Ma, Jian, Wei, Zhongheng. 2024. METTL16 inhibits pancreatic cancer proliferation and metastasis by promoting MROH8 RNA stability and inhibiting CAPN2 expression - experimental studies. In International journal of surgery (London, England), 110, 7701-7719. doi:10.1097/JS9.0000000000002116. https://pubmed.ncbi.nlm.nih.gov/39434688/
3. Blue, Elizabeth E, White, Janson J, Dush, Michael K, Nascone-Yoder, Nanette M, Bamshad, Michael J. 2023. Rare variants in CAPN2 increase risk for isolated hypoplastic left heart syndrome. In HGG advances, 4, 100232. doi:10.1016/j.xhgg.2023.100232. https://pubmed.ncbi.nlm.nih.gov/37663545/
4. Luo, Xi, Dong, Yunhua, Zheng, Haishan, Li, Yunxiu, Wu, Ze. 2024. CAPN2 correlates with insulin resistance states in PCOS as evidenced by multi-dataset analysis. In Journal of ovarian research, 17, 79. doi:10.1186/s13048-024-01407-2. https://pubmed.ncbi.nlm.nih.gov/38610028/
5. Zhao, Qiuyan, Xie, Haoran, Wang, Xing, Kuang, Shengli, Zhang, Bingyong. 2024. Comprehensive bioinformatics analysis of the prognostic value and immune infiltration of CAPN2 in pancreatic adenocarcinoma. In Gene, 934, 149035. doi:10.1016/j.gene.2024.149035. https://pubmed.ncbi.nlm.nih.gov/39454972/
6. Siuda, Daniel, Randriamboavonjy, Voahanginirina, Fleming, Ingrid. 2019. Regulation of calpain 2 expression by miR-223 and miR-145. In Biochimica et biophysica acta. Gene regulatory mechanisms, 1862, 194438. doi:10.1016/j.bbagrm.2019.194438. https://pubmed.ncbi.nlm.nih.gov/31634637/
智鼠故事 
